CRL — Charles River Laboratories International Share News
0.000.00%
Last trade - 00:00- $16.49bn
- $18.97bn
- $4.02bn
Charles River Laboratories Q3 revenue beats estimates
Brief: Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development
U.S. RESEARCH ROUNDUP- American Express, BlackRock, Domino's Pizza
Brief: Charles River Laboratories Announces Chief Financial Officer Transition
Medical device maker Insulet names industry veteran Flavia Pease as CFO (updated)
U.S. RESEARCH ROUNDUP-Autozone, Cognex, Royal Gold
U.S. RESEARCH ROUNDUP- IQVIA Holdings, Reliance, United Therapeutics
-Genuine Parts names 2 new directors after Elliott takes stake (updated)
Genuine Parts names 2 new directors after Elliott takes stake
Brief: Charles River Enhances Cell Therapy Flex Platform Through Collaboration With Akadeum Life Sciences
AI-driven drug discovery picks up as FDA pushes to reduce animal testing
Brief: Charles River Laboratories International Joins EASYGEN Consortium For CAR-T Therapy
Factbox: Healthcare firms see growing activist investor involvement in the past year
U.S. RESEARCH ROUNDUP-Applovin, Costco Wholesale, Hubspot
Charles River profit forecast clouded by order cancellations from biotechs (updated)
Charles River Laboratories International Inc reports results for the quarter ended June 30 - Earnings Summary
Charles River raises profit forecast on growing demand for drug development services
U.S. STOCKS ON THE MOVE-Alphabet, Warner Music Group, GeneDx
U.S. STOCKS ON THE MOVE-Nvidia, Eli Lilly, Canopy Growth